|
![]() |
|||
|
||||
OverviewThere has been growing interest in the use of cannabis-based products for the treatment of a wide range of diseases, including epilepsy. A number of studies were published during the last 5 years demonstrating efficacy of purified CBD for the control of a large spectrum of seizure-types, particularly those observed in severe childhood epilepsies, such as Lennox- Gastaut and Dravet syndromes. This book, co-authored by leaders in the field of epileptology, critically reviews recent data from clinical trials. Authors discuss issues related to pharmacology, drug interactions, efficacy, potential adverse events and long-term effects on development and behaviour. Child and adult neurologists and all clinicians contributing to epilepsy care will find useful information on the best practices, when using purified CBD for the treatment of drug-resistant epilepsies. Full Product DetailsAuthor: Alexis Arzimanoglou , Ulrich Brandl , Helen J Cross , Antonio Gil-NagelPublisher: John Libbey Eurotext Imprint: John Libbey Eurotext Weight: 0.162kg ISBN: 9782742016334ISBN 10: 2742016333 Pages: 68 Publication Date: 14 January 2021 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationAlexis Arzimanoglou, Department of Epilepsy, Sleep and Paediatric Neurophysiology, University Hospitals of Lyon (HCL) and Lyon Neuroscience Research Centre (CRNL), Lyon, France; Consultant Epilepsy Unit, Hospital San Juan de Dios, Barcelona, Spain. Tab Content 6Author Website:Countries AvailableAll regions |